Sa1553 METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) AND CLINICALLY SIGNIFICANT FIBROSIS ARE HIGHLY PREVALENT IN PCOS AND AN ALT >19 U/L IS THE OPTIMAL CUT-OFF FOR IDENTIFYING MASLD IN PCOS